Lexaria Bioscience Corp (LEXX)
3.90
-0.09
(-2.26%)
USD |
NASDAQ |
May 31, 16:00
3.87
-0.03
(-0.77%)
After-Hours: 20:00
Lexaria Bioscience Research and Development Expense (TTM): 2.961M for Feb. 29, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| February 29, 2024 | 2.961M |
| November 30, 2023 | 3.412M |
| August 31, 2023 | 3.667M |
| May 31, 2023 | 3.522M |
| February 28, 2023 | 2.634M |
| November 30, 2022 | 2.214M |
| August 31, 2022 | 1.843M |
| May 31, 2022 | 1.926M |
| February 28, 2022 | 1.629M |
| November 30, 2021 | 1.529M |
| August 31, 2021 | 1.263M |
| May 31, 2021 | 0.8916M |
| February 28, 2021 | 0.4617M |
| November 30, 2020 | 0.4719M |
| August 31, 2020 | 0.3871M |
| May 31, 2020 | 0.4802M |
| February 29, 2020 | 0.6867M |
| November 30, 2019 | 0.5662M |
| Date | Value |
|---|---|
| August 31, 2019 | 0.5557M |
| May 31, 2019 | 0.6077M |
| February 28, 2019 | 0.4698M |
| November 30, 2018 | 0.4794M |
| August 31, 2018 | 0.4929M |
| May 31, 2018 | 0.3101M |
| February 28, 2018 | 0.2253M |
| November 30, 2017 | 0.1573M |
| August 31, 2017 | 0.0542M |
| May 31, 2017 | 0.0233M |
| February 28, 2017 | 0.0152M |
| November 30, 2016 | 0.0143M |
| August 31, 2016 | 0.009M |
| May 31, 2016 | 0.1071M |
| February 29, 2016 | 0.107M |
| November 30, 2015 | 0.1004M |
| August 31, 2015 | 0.1465M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
0.3871M
Minimum
Aug 2020
3.667M
Maximum
Aug 2023
1.637M
Average
1.529M
Median
Nov 2021
Research and Development Expense (TTM) Benchmarks
| Sunshine Biopharma Inc | 1.645M |
| Acasti Pharma Inc | 4.638M |
| Aurinia Pharmaceuticals Inc | 49.64M |
| Edesa Biotech Inc | 3.860M |
| Xenon Pharmaceuticals Inc | 172.25M |